Home > Healthcare > Medical Devices > Diagnostic Devices > HIV Diagnostics Market
HIV Diagnostics Market Share
- Report ID: GMI491
- Published Date: Apr 2022
- Report Format: PDF
HIV Diagnostics Market Share
Some of the notable industry players operating in the HIV diagnostics industry include
- Chembio Diagnostics
- OraSure Technologies
- Abbott Laboratories
- Becton Dickinson and company
- Cepheid
- Omega Diagnostics
- BIONEER CORPORATION
- Roche Diagnostics
- Biomerieux
- Qiagen
These market players are adopting numerous growth strategies such as collaboration, acquisition & merger, partnership and product launches to sustain market competition in HIV diagnostics market.
Frequently Asked Questions (FAQ) :
HIV diagnostics market value exceeded USD 690 million in 2021 and is expected to grow at a CAGR of 0.8% over 2022-2028, driven by the surging disease burden of HIV infections in developing nations.
The market size from diagnostics laboratories is anticipated to expand at a CAGR of 0.8% from 2022 to 2028 driven by continuous technological advancements in laboratory devices.
HIV diagnostic industry share from viral load test type was over USD 450 million during 2021 and will expand as these tests help to enhance the quality and outcome of treatment for infected people.
Africa HIV diagnostics market share accounted for 38% of the overall industry revenue in 2021 and will exhibit consistent growth due to the increasing awareness initiatives by private and government players.
HIV Diagnostics Market Scope
×
Get a free sample of
HIV Diagnostics Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below